G’day Great Lakes NeuroTechnologies

Valley View-based Great Lakes NeuroTechnologies have received TGA approval to market their Kinesia technology in Australia. The product line  includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated with Parkinson’s disease and in response to treatments.

Market applications include both in-clinic and home-based telemedicine patient care, assistance in programming deep brain stimulation, and providing quantitative endpoints to determine efficacy in clinical trials.

 

“Achieving TGA certification to market in Australia represents our commitment to delivering innovative, high quality medical technology and increasing our growth in international markets,” said Dave Tucholski, director of Quality and Regulatory Affairs. “This expands upon our previous regulatory successes including FDA clearance, CE Mark, and ISO certification.”

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Norwood Medical in Dayton planning $13.5M expansion, adding 50 jobs | Dayton Business Journal, September 17, 2014

Youngstown Business Incubator and TechColumbus 1st and 3rd university associated incubators in the world | UBI Index, September 16, 2014

Enable Injections featured in article on safer, simpler, smarter devices for drug delivery | Drug Development & Delivery, September 15, 2014

BioOhio takes 2014 Annual Conference “on the road” in series of three regional events | Business Wire, September 15, 2014

ABC’s of IND’s – ChanTest to Host Session at the Safety Pharmacology Society (SPS) Annual Meeting | PR Web, September 15, 2014

Nationwide Children’s Hospital discusses Enterovirus D68 | Nationwide Children's Hospital, September 12, 2014

Akebia Therapeutics (NASDAQ: AKBA) to ring the NASDAQ Stock Market Opening Bell | NASDAQ, September 11, 2014

$1M grant to Cincinnati Children’s intended to improve human growth and development around the world | CCHMC, September 10, 2014

Airway Therapeutics gets money to advance treatment for smallest and sickest babies | WCPO9 Cincinnati, September 10, 2014

Airway Therapeutics raises $4.6M in Series A financing | CincyTech, September 10, 2014

Airway Therapeutics announces $4.6M funding round | Cincinnati.com, September 10, 2014

Alkermes anti-addiction drug Vivitrol helping inmates at Barnstable County Correctional Facility (MA) | Boston Business Journal, September 8, 2014

Nationwide Children’s Hospital now home to the world’s largest Ronald McDonald House | Columbus Dispatch, September 8, 2014

Envision Pharmaceutical completes its acquisition of MedTrak Services (Kansas) | Herald Online, September 8, 2014

Ohio Capital Fund key player in state startup scene | Cincinnati.com, September 6, 2014

Navidea enters Lymphoseek development and commercialization agreement with Hainan Sinotau Pharmaceutical Co., Ltd. subsidiary in China | Navidea Pharmaceuticals, September 4, 2014

Ricerca Biosciences in discussions to be acquired | OutsourcingPharma.com, September 3, 2014

Meridian Bioscience signs agreement with Premier to offer its hospitals molecular diagnostic tests and instruments | Business Wire, September 3, 2014

Cleveland Functional Electrical Stimulation Center taking toy donations at Expo to help disabled children | WKYC3 NBC, September 2, 2014

Aerpio Therapeutics announces publication of preclinical data on AKB-9778 for common eye diseases | Business Wire, September 2, 2014